Back to Agenda
Key Initiatives in Europe to Walk the Talk in Patient-Focused Medicines Development - An interactive update and Discussion with Different Stakeholders
Session Chair(s)
Lode Dewulf
Patient and Medical Affairs Consultant, Corvalus, Belgium
Health stakeholders agree on the importance of improving patient engagement (PE) across all phases of medicines development. What can we learn from the experience and perspectives of different stakeholders? How can we use these insights to address challenges and barriers and forge a more collaborative, connected PE ecosystem? What tools are available or in co-creation and how can we measure the impact of our PE efforts? Join us for a dynamic session that will explore these themes, and be an active participant by selecting priority topics to be addressed by PE leaders from diverse stakeholder groups.
Speaker(s)
Mathieu Boudes, PHD
Patient Engagement Director, Montsouris Consilium, France
Panel Discussion
Neil Bertelsen, MBA, MSC
Patient Engagement Specialist, Neil Bertelsen Consulting, Germany
Panel Discussion
Soren E Skovlund
Senior Reaearcher, lead, PRO, Aalborg University, Denmark
Panel Discussion
Nicholas Brooke, MBA
Executive Director, Patient Focused Medicines Development (PFMD), The Synergist, Belgium
Panel Discussion
Have an account?